Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.77
APDN's Cash to Debt is ranked higher than
99% of the 1248 Companies
in the Global Biotechnology industry.

( Industry Median: 67.35 vs. APDN: 0.77 )
APDN' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.77

Equity to Asset -0.42
APDN's Equity to Asset is ranked higher than
52% of the 928 Companies
in the Global Biotechnology industry.

( Industry Median: 0.67 vs. APDN: -0.42 )
APDN' s 10-Year Equity to Asset Range
Min: -7.6   Max: 0.56
Current: -0.42

-7.6
0.56
Interest Coverage No Debt
APDN's Interest Coverage is ranked higher than
90% of the 577 Companies
in the Global Biotechnology industry.

( Industry Median: 10000.00 vs. APDN: No Debt )
APDN' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 3
Z-Score: -85.47
M-Score: -6.21
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -450.94
APDN's Operating margin (%) is ranked higher than
62% of the 1027 Companies
in the Global Biotechnology industry.

( Industry Median: -78.88 vs. APDN: -450.94 )
APDN' s 10-Year Operating margin (%) Range
Min: -82663.16   Max: -350.84
Current: -450.94

-82663.16
-350.84
Net-margin (%) -480.23
APDN's Net-margin (%) is ranked higher than
60% of the 1027 Companies
in the Global Biotechnology industry.

( Industry Median: -78.05 vs. APDN: -480.23 )
APDN' s 10-Year Net-margin (%) Range
Min: -12684.21   Max: 1337.29
Current: -480.23

-12684.21
1337.29
ROE (%) -1301.23
APDN's ROE (%) is ranked lower than
52% of the 1143 Companies
in the Global Biotechnology industry.

( Industry Median: -35.75 vs. APDN: -1301.23 )
APDN' s 10-Year ROE (%) Range
Min: -7139.36   Max: -658.33
Current: -1301.23

-7139.36
-658.33
ROA (%) -254.47
APDN's ROA (%) is ranked lower than
51% of the 1250 Companies
in the Global Biotechnology industry.

( Industry Median: -28.24 vs. APDN: -254.47 )
APDN' s 10-Year ROA (%) Range
Min: -13396.54   Max: 235.24
Current: -254.47

-13396.54
235.24
ROC (Joel Greenblatt) (%) -1867.58
APDN's ROC (Joel Greenblatt) (%) is ranked higher than
64% of the 1223 Companies
in the Global Biotechnology industry.

( Industry Median: -438.40 vs. APDN: -1867.58 )
APDN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -287272.22   Max: -1929.56
Current: -1867.58

-287272.22
-1929.56
Revenue Growth (%) 10.10
APDN's Revenue Growth (%) is ranked higher than
90% of the 723 Companies
in the Global Biotechnology industry.

( Industry Median: -2.20 vs. APDN: 10.10 )
APDN' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 81.7
Current: 10.1

0
81.7
EBITDA Growth (%) -10.30
APDN's EBITDA Growth (%) is ranked higher than
70% of the 710 Companies
in the Global Biotechnology industry.

( Industry Median: -5.80 vs. APDN: -10.30 )
APDN' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 1.4
Current: -10.3

0
1.4
EPS Growth (%) -16.60
APDN's EPS Growth (%) is ranked higher than
80% of the 728 Companies
in the Global Biotechnology industry.

( Industry Median: -7.40 vs. APDN: -16.60 )
APDN' s 10-Year EPS Growth (%) Range
Min: -64.9   Max: 549.9
Current: -16.6

-64.9
549.9
» APDN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

APDN Guru Trades in

Q1 2014

APDN Guru Trades in Q1 2014

Ken Fisher 20,000 sh (New)
» More
Q2 2014

APDN Guru Trades in Q2 2014

Ken Fisher 10,000 sh (-50%)
» More
Q3 2014

APDN Guru Trades in Q3 2014

Ken Fisher 10,000 sh (New)
Ken Fisher Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with APDN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ken Fisher 2014-09-30 Sold Out $5.472 - $7.38 $ 3.05-53%0
Ken Fisher 2014-06-30 Reduce -50%$6.06 - $8.22 $ 3.05-58%166.67
Ken Fisher 2014-03-31 New Buy$7.26 - $9.9 $ 3.05-64%333.34
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 14.40
APDN's P/S is ranked higher than
80% of the 1333 Companies
in the Global Biotechnology industry.

( Industry Median: 28.86 vs. APDN: 14.40 )
APDN' s 10-Year P/S Range
Min: 7.5   Max: 1620
Current: 14.4

7.5
1620
EV-to-EBIT -3.50
APDN's EV-to-EBIT is ranked higher than
50% of the 1333 Companies
in the Global Biotechnology industry.

( Industry Median: 9999.00 vs. APDN: -3.50 )
APDN' s 10-Year EV-to-EBIT Range
Min: -24.7   Max: -0.4
Current: -3.5

-24.7
-0.4
Current Ratio 0.61
APDN's Current Ratio is ranked higher than
57% of the 1238 Companies
in the Global Biotechnology industry.

( Industry Median: 4.74 vs. APDN: 0.61 )
APDN' s 10-Year Current Ratio Range
Min: 0.02   Max: 6.46
Current: 0.61

0.02
6.46
Quick Ratio 0.61
APDN's Quick Ratio is ranked higher than
60% of the 1238 Companies
in the Global Biotechnology industry.

( Industry Median: 4.57 vs. APDN: 0.61 )
APDN' s 10-Year Quick Ratio Range
Min: 0.02   Max: 6.46
Current: 0.61

0.02
6.46

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 0.10
APDN's Price/DCF (Projected) is ranked higher than
50% of the 1333 Companies
in the Global Biotechnology industry.

( Industry Median: 9999.00 vs. APDN: 0.10 )
APDN' s 10-Year Price/DCF (Projected) Range
Min: 0.11   Max: 0.16
Current: 0.1

0.11
0.16
Price/Median PS Value 0.40
APDN's Price/Median PS Value is ranked higher than
97% of the 1333 Companies
in the Global Biotechnology industry.

( Industry Median: 2.20 vs. APDN: 0.40 )
APDN' s 10-Year Price/Median PS Value Range
Min: 0.24   Max: 14.63
Current: 0.4

0.24
14.63
Earnings Yield (Greenblatt) -28.50
APDN's Earnings Yield (Greenblatt) is ranked higher than
54% of the 1218 Companies
in the Global Biotechnology industry.

( Industry Median: -6.30 vs. APDN: -28.50 )
APDN' s 10-Year Earnings Yield (Greenblatt) Range
Min: -28.5   Max: 0
Current: -28.5

-28.5
0

Business Description

Industry: Biotechnology » Biotechnology
Compare: » details
Applied DNA Sciences, Inc. is a Delaware Corporation. It was initially formed in 1983 under the laws of the State of Florida as Datalink Systems, Inc. In 1998, it reincorporated in Nevada, and in 2002, it changed its name to its current name, Applied DNA Sciences, Inc. In December 2008, it completed its reincorporation from Nevada to the State of Delaware. The Company is a provider of botanical-DNA based security and authentication solutions that could help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The Company creates unique security solutions addressing the challenges of modern commerce. SigNature DNA is a platform ingredient, at the core of all the Company's security solutions. SigNature DNA is based on full, double stranded plant DNA, and provides forensic power and protection for a wide array of applications. SigNature DNA markers are an ingredient that can be used to fortify brand protection efforts; mark, track and convict criminals; and strengthen supply chain security. Custom DNA sequences can be embedded into a wide range of host carriers including ink, varnish, thread, laminates and metal coatings. SigNature T botanical DNA markers are used for brand protection efforts and raw material source compliance programs. This fiberTyping process provides DNA verification to help manufacturers, retailers and brand owners ensure quality, safety and compliance of their products. DNANet, a botanical DNA marker can be used to definitively link evidence and offenders to specific crime scenes. Whether deployed as a residential asset marker, an offender spray in a retail location or a degradation dye in cash handling boxes, DNA markers facilitate conviction, and establish a heightened level of deterrence. SmartDNA is a unique and patented security system based on botanical DNA, a new and effective crime protection system for stores, warehouses, banks, pharmacies, ATMs and the protection of valuables. The system contains a water-based, non-toxic spray which may be triggered during a crime, marking the perpetrator and remaining on their person for weeks after the crime. Each SmartDNA product is designed to be unique to each store, warehouse or sting operation, allowing the police and prosecutors to link criminals to the crimes. digitalDNA is a new security tool that utilizes the flexibility of mobile communications, the instant accessibility of secure, cloud-based data, and the absolute certainty of DNA to make item tracking and authentication fast, easy and definitive, while providing the opportunity to create a new customer interface. digitalDNA is a DNA-secured form of the QR code. The product uses forensic authentication of a botanical DNA marker, sequence-encrypted within a secure QR code, and physically included within the ink used to digitally print the code. The Company competes with existing suppliers and new competitors and continu
» More Articles for APDN

Headlines

Articles On GuruFocus.com
DNA identification. Mar 31 2013 

More From Other Websites
Applied DNA Sciences Invited to Serve on AATCC Fiber Analysis Test Committee Dec 18 2014
APDN Reports Record Revenue for Fiscal Year 2014 Dec 17 2014
Applied DNA Sciences Reports Fiscal Year End 2014 Results Dec 16 2014
Applied DNA Sciences Reports Fiscal Year End 2014 Results Dec 16 2014
Applied DNA Sciences' Anti-Theft System Recommended by Sweden Police, Insurance Officials Dec 16 2014
APPLIED DNA SCIENCES INC Files SEC form 10-K, Annual Report Dec 15 2014
Applied DNA Sciences Elects Joseph Ceccoli to Board of Directors Dec 10 2014
APPLIED DNA SCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers Dec 09 2014
Applied DNA Sciences Elects Joseph Ceccoli to Board of Directors Dec 09 2014
Applied DNA Sciences Schedules Fiscal Fourth Quarter and Year-End 2014 Webcast for December 16, 2014... Dec 08 2014
Applied DNA Sciences Schedules Fiscal Fourth Quarter and Year-End 2014 Webcast for December 16, 2014... Dec 08 2014
Applied DNA Sciences to Participate in Two Investor Conferences on Thursday, December 11 Dec 04 2014
Applied DNA Sciences Signs With Fourth Federal Agency Dec 04 2014
APPLIED DNA SCIENCES INC Financials Nov 21 2014
APPLIED DNA SCIENCES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 20 2014
Applied DNA Sciences Inc. Announces Closing of $9.1 Million Underwritten Offering Nov 20 2014
Applied DNA Sciences Inc. Announces Uplisting to NASDAQ and Pricing of $9.1 Million Underwritten... Nov 17 2014
Applied DNA Sciences Inc. Announces Uplisting to NASDAQ and Pricing of $9.1 Million Underwritten... Nov 17 2014
APDN: Price Target Adjusted Reflecting Recent Reverse Stock Split Nov 13 2014
Applied DNA Sciences and MSS Professional A/S Win Popular Science Best of What’s New, 2014 Nov 12 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK